WAVE Life Sciences (WVE) Misses Q2 EPS by 11c

WAVE Life Sciences (NASDAQ: WVE) reported Q2 EPS of ($0.62), $0.11 worse than the analyst estimate of ($0.51).

For earnings history and earnings-related data on WAVE Life Sciences (WVE) click here.

You May Also Be Interested In

• Paychex (PAYX) Tops Q1 EPS by 2c
• UBS Reiterates Buy Rating on KB Home (KBH) Amid Transition Back to Built-to-Order
• Cintas Corp. (CTAS) Tops Q1 EPS by 1c, Offers Guidance